Changes in body composition during breast cancer chemotherapy with the CMF-regimen

Breast Cancer Research and Treatment

Volumn 57, Issue 3, 1999, Pages 285-290

  Aslani, A ^a   Smith, R C ^a   Allen, B J ^a   Pavlakis, N ^a   Levi, J A ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Breast cancer; Chemotherapy; CMF; Weight gain

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; NITROGEN;

ADULT; AGED; ALOPECIA; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT DISORDER; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; DIARRHEA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MUCOSA INFLAMMATION; NAUSEA; NEUTRON CAPTURE THERAPY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TOTAL BODY WATER; VOMITING; WEIGHT GAIN;

ADULT; AGED; ANTHROPOMETRY; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY COMPOSITION; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; FEMALE; FLUOROURACIL; HUMANS; METHOTREXATE; MIDDLE AGED; PROGNOSIS; STRESS, PSYCHOLOGICAL; WEIGHT GAIN;

EID: 0032785541     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006220510597     Document Type: Article

References (38)

1. 1. Heasman KZ, Sutherland HJ, Campbell JA, Elhakim T, Boyd NF: Weight gain during adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat 5: 195-200, 1985
2. 2. Macfie J, Burkinshaw L: Body composition in malignant disease. Metabolism 36: 290-294, 1987
3. 3. Huntington MO: Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast. Cancer 56: 472-474, 1985
4. 4. Demark-Wahnefried W, Winer EP, Rimer BK: Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol 11: 1418-1429, 1993
5. 5. Allen BJ, Blagojevic N, Delaney I, Pollock CA, Ibels LS, Allman MA, Tiller DJ, Gaskin KJ, Baur LA, Waters DL, Cowell CT, Ambler G, Quigley C, Fletcher JP: The role of body protein studies in clinical trials. Basic Life Sci 55: 155-169, 1990
6. 6. Early Breast Cancer Trialists' Collaboration Group: World wide evidence: treatment of early breast cancer (1985-1990). Oxford Medical Publications, Oxford, 1990
7. 7. Lindeman GJ, Boyages J, Driessen C, Langlands AO: Intravenous or oral adjuvant CMF for node-positive breast cancer. Aust NZ J Surg 62: 556-562, 1992
8. 8. Brincker H, Mouridsen HT, Andersen KW: Adjuvant chemotherapy with cyclophosphamide or CMF in premenopausal women with stage II breast cancer. Breast Cancer Res Treat 3: 91-95, 1983
9. 9. Wood WC, Weiss RB, Tormey DC, Holland JF, Henry PH, Leone LA, Rafla S, Silver RT, Carey RW, Lesnick GJ, et al.: A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: a CALGB Study. World J Surg 9: 714-718, 1985
10. 10. Tancini G, Bonadonna G, Valagussa P, Marchini S, Veronesi U: Adjuvant CMF in breast cancer: comparative 5-year results of 12 versus 6 cycles. J Clin Oncol 1: 2-10, 1983
11. 11. Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, De Lena M, Tancini G, Bajetta E, Musumeci R, Veronesi U: Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 294: 405-410, 1976
12. 12. Goodwin PJ, Panzarella T, Boyd NF: Weight gain in women with localized breast cancer-a descriptive study. Breast Cancer Res Treat 11: 59-66, 1988
13. 13. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH: Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 8: 1327-1334, 1990
14. 14. Cheney CL, Mahloch J, Freeny P: Computerized tomography assessment of women with weight changes associated with adjuvant treatment for breast cancer. Am J Clin Nutr 66: 141-146, 1997
15. 15. Aslani A, Smith RC, Allen BJ, Levi JA: Changes in body composition during adjuvant chemotherapy for breast cancer. Appl Radiat Isot 49: 637-638, 1998
16. 16. Durnin JV, Rahaman MM: The assessment of the amount of fat in the human body from measurements of skinfold thickness. Br J Nutr 21: 681-689, 1967
17. 17. Durnin JV, Womersley J: Total body fat, calculated from body density, and its relationship to skinfold thickness in 571 people aged 12-72 years. Proc Nutr Soc 32: 45A, 1973
18. 18. Durnin JV, Armstrong WH, Womersley J: An experimental study on the variability of measurements of skinfold thicknesses by three observers on twenty-three young women and twenty-seven young men. Proc Nutr Soc 30: 9A-10A, 1971
19. 19. Durnin JV, Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32: 77-97, 1974
20. 20. Pollock CA, Ibels LS, Allen BJ, Ayass W, Caterson RJ, Waugh DA, Macadam C, Pennock Y, Mahony JF: Total body nitrogen as a prognostic marker in maintenance dialysis. J Am Soc Nephrol 6: 82-88, 1995
21. 21. Allen BJ, Blagojevic N, McGregor BJ, Parsons DE, Gaskin KJ, Soutter VL, Waters DL, Allman MA, Stewart PJ, Tiller DJ: In vivo determination of protein in malnourished patients. In: Ellis KJ, Yasumura S, Morgan WD (eds) In vivo Body Composition Studies. Institute of Physical Sciences in Medicine, London, 1987, pp 77-82
22. 22. Baur LA, Knight JF, Crawford BA, Reed E, Roy LP, Allen BJ, Gaskin KJ: Total body nitrogen in children with chronic renal failure and short stature. Eur J Clin Nutr 48: 433-441, 1994
23. 23. Allen BJ, Bailey GM, McGregor BJ: Dose equivalent distributions in the AAEC total body nitrogen facility. In: Anonymous Proceedings of the Fourth Australian Conference on Nuclear Techniques of Analysis. AINSE, Sydney, 1985, pp. 168-170
24. 24. Baur LA, Waters DL, Allen BJ, Blagojevic N, Gaskin KJ: Nitrogen deposition in malnourished children with cystic fibrosis. Am J Clin Nutr 53: 503-511, 1991
25. 25. Vartsky D, Prestwich WV, Thomas BJ, Dabek JT, Chettle DR, Fremlin JH, Stammers K: The use of body hydrogen as an internal standard in the measurement of nitrogen in vivo by prompt neutron capture gamma-ray analysis. J Radioanal Chem 48: 243-252, 1979
26. 26. Blagojevic N, Allen BJ, Gaskin KJ, Baur LA: Determination of total body water by Fourier transform infrared analysis. Australas Phys Eng Sci Med 13: 110-116, 1990
27. 27. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet Feb 8: 307-310, 1986
28. 28. Cohn SH, Ellis KJ, Vartsky D, Sawitsky A, Gartenhaus W, Yasumura S, Vaswani AN: Comparison of methods of estimating body fat in normal subjects and cancer patients. Am J Clin Nutr 34: 2839-2847, 1981
29. 29. Cohn SH, Gartenhaus W, Sawitsky A, Rai K, Zanzi I, Vaswani A, Ellis KJ, Yasumura S, Cortes E, Vartsky D: Compartmental body composition of cancer patients by measurement of total body nitrogen, potassium, and water. Metabolism 30: 222-229, 1981
30. 30. Le Bricon T, Gugins S, Cynober L, Baracos VE: Negative impact of cancer chemotherapy on protein metabolism in healthy and tumor-bearing rats. Metabolism 44: 1340-1348, 1995
31. 31. Harvey KB, Bothe A, Blackburn GL: Nutritional assessment and patient outcome during oncological therapy. Cancer 43: 2065-2069, 1979
32. 32. Wilmore DW: Catabolic illness. Strategies for enhancing recovery. N Engl J Med 325: 695-702, 1991
33. 33. Donaldson SS, Lenon RA: Alterations of nutritional status: impact of chemotherapy and radiation therapy. Cancer 43: 2036-2052, 1979
34. 34. Levine EG, Raczynski JM, Carpenter JT: Weight gain with breast cancer adjuvant treatment. Cancer 67: 1954-1959, 1991
35. 35. Kelsey JL: Breast cancer epidemiology: summary and future directions. Epidemiol Rev 15: 256-263, 1993
36. 36. Schapira DV, Nagi BK, Lyman GH: Estimate of breast cancer risk reduction. Cancer 26: 2622-2625, 1991
37. 37. Bonadonna G, Valagussa P, Rossi A, Tancini G, Brambilla C, Zambelti M, Veronesi U: Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat 5: 95-115, 1985
38. 38. Georgiadis MS, Steinberg SM, Hankins LA, Ihde DC, Johnson BE: Obesity and therapy-related toxicity in patients treated for small-cell lung cancer. J Natl Cancer Inst 87: 361-366, 1995